The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Constitutive Activity of the Serotonin2C Receptor Inhibits In Vivo Dopamine Release in the Rat Striatum and Nucleus Accumbens
Open accessAbstract
Numerous research has pointed out that serotonin2c (5-HT 2C) receptor, a subtype of 5-HT receptors belonging to the G-protein-coupled receptor superfamily, modulates the activity of mesencephalic dopamine (DA) neurons, the dysfunction of which is involved in devastating diseases such as schizophrenia, Parkinson's disease, and drug addiction. In the present study, using in vivo intracerebral microdialysis and Chinese hamster ovary (CHO) cells expressing 5-HT 2C receptors to identify appropriate 5-HT 2C receptor ligands, we sought to determine whether the property of 5-HT 2C receptors to spontaneously activate intracellular signaling pathways in vitro(constitutive activity) participates in the tonic inhibitory control that they exert on DA release in the rat striatum and nucleus accumbens in vivo. In CHO cells, the purported antagonist 5-methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f] indole hydrochloride (SB 206553), but not 6-chloro-5-methyl-1-[6-(2-methylpiridin-3-yloxy)pyridin-3-yl carbamoyl] indoline (SB 242084), decreased basal inositol phosphate accumulation, thus behaving as a 5-HT 2C inverse agonist. Its effect was prevented by SB 242084.In vivo, SB 206553 (1–10 mg/kg) elicited a dose-dependent and clear-cut increase in accumbal and striatal DA release compared with SB 242084 (1–10 mg/kg), and the 5-HT 2C agonist S-2-(6-chloro-5-fluoroindol-1-yl)-1-methylethylamine hydrochloride (Ro-60-0175) (0.3–3 mg/kg) inhibited DA release. Pretreatment by SB 242084 reversed the change in DA release elicited by Ro-60-0175 and SB 206553. Furthermore, SB 206553-stimulated DA release was insensitive to reduction of 5-HT neuronal function induced by the 5-HT 1A agonist (±)-8-hydroxy-2-dipropylaminotetralin or intra-raphe injections of 5,7-dihydroxytryptamine neurotoxin. The obtained results provide the first in vivo evidence that constitutive activity of the 5-HT 2C receptor tonically inhibits mesencephalic DA neurons and underscore the need for a better understanding of the pathophysiological role of constitutive receptor activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
A stereotaxic atlas of the rat brain
Pellegrino, L. J., & Cushman, A. J. (1967) · Plenum Press eBooks · Cited by 4,688
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors
Tecott, L. H., Sun, L. M., Akana, S. F., Strack, A. M., Lowenstein, D. H., Dallman, M. F., & Julius, D. (1995) · Nature · doi:10.1038/374542a0 · Cited by 1,274
Regulation of serotonin-2C receptor G-protein coupling by RNA editing
Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E., & Emeson, R. B. (1997) · Nature · doi:10.1038/387303a0 · Cited by 1,010 · cited 1×
“In this respect, RNA editing of the transcript encoding 5-HT2C receptors ( Burns et al., 1997 ), by lowering constitutive activity of the native product (Niswender et al., 1999), might represent a determining factor in organizing the strength of 5-HT2C receptor influence at central 5-HT synapses (Price et al., 2001).”
BackgroundNucleus accumbens shell and core dopamine: differential role in behavior and addiction
Di Chiara, G. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00286-3 · Cited by 996 · cited 1×
“…of ascending mesencephalic dopamine (DA) neurons is critical for normal brain function, and aberration in their functional status contributes to various devastating diseases and conditions such as schizophrenia, Parkinson's disease, and drug addiction (Dunnett and Robbins, 1992; Di Chiara, 2002).”
BackgroundSerotonin-dopamine interaction and its relevance to schizophrenia
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.4.466 · Cited by 823
Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins
Lefkowitz, R. J., Cotecchia, S., Samama, P., & Costa, T. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90048-o · Cited by 792
The Role of Serotonin in Antipsychotic Drug Action
Meltzer, H. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00046-9 · Cited by 662
Agonist-receptor efficacy II: agonist trafficking of receptor signals
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89032-x · Cited by 657
SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist
KENNETT, G. A., WOOD, M. D., BRIGHT, F., TRAIL, B., RILEY, G., HOLLAND, V., AVENELL, K. Y., STEAN, T., UPTON, N., BROMIDGE, S., et al. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00038-5 · Cited by 523
High constitutive activity of native H3 receptors regulates histamine neurons in brain
Morisset, S., Rouleau, A., Ligneau, X., Gbahou, F., Tardivel-Lacombe, J., Stark, H., Schunack, W., Ganellin, C. R., & Arrang, J.-M. (2000) · Nature · doi:10.1038/35048583 · Cited by 461
Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
KENAKIN, T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0438rev · Cited by 408
RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity
Niswender, C. M., Copeland, S. C., Herrick-Davis, K., Emeson, R. B., & Sanders-Bush, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9472 · Cited by 363
Gobert, A., Rivet, J.-M., Lejeune, F., Newman-Tancredi, A., Adhumeau-Auclair, A., Nicolas, J.-P., Cistarelli, L., Melon, C., & Millan, M. J. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000601)36:3<205::aid-syn5>3.0.co;2-d · Cited by 336
5-HT2C Receptor Agonists: Pharmacological Characteristics and Therapeutic Potential
Martin, J. R., Bös, M., Jenck, F., Moreau, J.-L., Mutel, V., Sleight, A. J., Wichmann, J., Andrews, J. S., Berendsen, H. H. G., Broekkamp, C. L. E., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37669-4 · Cited by 334
Sharp, T., Bramwell, S. R., & Grahame‐Smith, D. G. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11815.x · Cited by 321
Niswender, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00223-2 · Cited by 256
Barker, E. L., Westphal, R. S., Schmidt, D., & Sanders-Bush, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32625-x · Cited by 254
Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats
Eberle-Wang, K., Mikeladze, Z. A., Uryu, K., & Chesselet, M. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970728)384:2<233::aid-cne5>3.0.co;2-2 · Cited by 251
Kennett, G. A., Wood, M. D., Bright, F., Cilia, J., Piper, D. C., Gager, T., Thomas, D., Baxter, G. S., Forbes, I. T., Ham, P., et al. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15208.x · Cited by 240
Role of 5-HT2C receptors in the control of central dopamine function
Di Matteo, V., De Blasi, A., Di Giulio, C., & Esposito, E. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01688-6 · Cited by 234
Sharp, T., Bramwell, S. R., Clark, D., & Grahame‐Smith, D. G. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07319.x · Cited by 224
Porras, G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00333-5 · Cited by 222
Di Giovanni, G., De Deurwaerdére, P., Di Mascio, M., Di Matteo, V, Esposito, E., & Spampinato, U. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00655-1 · Cited by 218
Self-citationBaumgarten, H. G., Björklund, A., Lachenmayer, L., & Nobin, A. (1973) · PubMed · Cited by 214
Studies to Investigate the Role of 5-HT2C Receptors on Cocaine- and Food-Maintained Behavior
Grottick, A. J., Fletcher, P. J., & Higgins, G. A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39021-4 · Cited by 211
Herrick‐Davis, K., Grinde, E., & Niswender, C. M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.731711.x · Cited by 180
Rocha, B. A., Goulding, E. H., O'Dell, L. E., Mead, A. N., Coufal, N. G., Parsons, L. H., & Tecott, L. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-10039.2002 · Cited by 158
Deurwaerdère, P. D., Stinus, L., & Spampinato, U. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06528.1998 · Cited by 152
Self-citationRauser, L., Savage, J. E., Meltzer, H. Y., & Roth, B. L. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29304-6 · Cited by 144
THE FUNCTIONAL ROLE OF MESOTELENCEPHALIC DOPAMINE SYSTEMS
Dunnett, S. B., & Robbins, T. W. (1992) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.1992.tb01191.x · Cited by 140
Soubrié, P., Reisine, T., & Glowinski, J. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90082-4 · Cited by 137
RNA Editing of the Human Serotonin 5-HT2CReceptor Alters Receptor-mediated Activation of G13Protein
Price, R. D., Weiner, D. M., Chang, M., & Sanders‐Bush, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106745200 · Cited by 112
Andersson, J. L., Nomikos, G. G., Marcus, M. M., Hertel, P., Mathé, J. M., & Svensson, T. H. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00172774 · Cited by 102
Novel Actions of Inverse Agonists on 5-HT2C Receptor Systems
Berg, K. A., Stout, B. D., Cropper, J. D., Maayani, S., & Clarke, W. P. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23183-7 · Cited by 100
Self-citationEvans, N. A., Groarke, D. A., Warrack, J., Greenwood, C. J., Dodgson, K., Milligan, G., & Wilson, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00269.x · Cited by 80
Willins, D. L., & Meltzer, H. Y. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01267-5 · Cited by 74
Pleiotropic Behavior of 5‐HT2A and 5‐HT2C Receptor Agonists
Berg, K. A., Clarke, W. P., Maayani, S., et al. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10180.x · Cited by 69
Self-citationKirby, L. G., Kreiss, D. S., Singh, A., & Lucki, I. (1995) · Synapse · doi:10.1002/syn.890200202 · Cited by 50
Deurwaerdère, P. D., & Chesselet, M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-13-05170.2000 · Cited by 46
Evans, K. L. J., Cropper, J. D., Berg, K. A., & Clarke, W. P. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29629-4 · Cited by 32
Self-citation
Cited by
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Self-citationNew insights into symptoms and neurocircuit function of anorexia nervosa
Kaye, W. H., Fudge, J. L., & Paulus, M. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2682 · Cited by 843
“Indeed, studies of animals show that 5-HT 2C receptors tonically inhibit DA neurons 91,92 .”
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission
Alex, K. D., & Pehek, E. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.004 · Cited by 658
Kenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Metadata
- Authors
- De Deurwaerdère, P., Navailles, S., Berg, K. A., Clarke, W. P., & Spampinato, U.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2004-03-31
- Volume
- 24
- Issue
- 13
- Pages
- 3235-3241
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1623913572
- Cited by
- 306
- References
- 42
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.